- Lobbying
- Lobbying by Biotechnology Industry Organization
Lobbying Relationship
Bills mentioned
H.R.873: Stem Cell Research Enhancement Act of 2009
Sponsor: Diana DeGette (D-Colo.)
S.487: Stem Cell Research Enhancement Act of 2009
Sponsor: Tom Harkin (D-Iowa)
H.R.872: Stem Cell Research Improvement Act of 2009
Sponsor: Diana DeGette (D-Colo.)
H.R.7141: Stem Cell Research Enhancement Act of 2008
Sponsor: Diana DeGette (D-Colo.)
S.5: Stem Cell Research Enhancement Act of 2007
Sponsor: Harry Reid (D-Nev.)
H.R.3: Stem Cell Research Enhancement Act of 2007
Sponsor: Diana DeGette (D-Colo.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Michael Werner | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate